Survey on non – interventional studies (NIS) Cologne, March 16, 2010 a few years ago non – interventional studies had a bad reputation. Learn more on the subject from Joel Courtney. Focused too much on marketing interests, the real significance of the studies in the background was marginalized. One shows that a reversal is discernible, doccheck of the Rottapharm Madaus GmbH carried out survey. The survey of 100 general practitioners, internists, and practitioners brought optimistic views on the image of the non – Interventional trial days. So, 36 percent of the doctors agreed that application observations have taken their original significance to generate scientific data to the practice application again. 14 percent of them agreed to even fully this statement.

And only 10 percent could not or not at all to share this opinion. It’s great that application observations slowly regain a positive image. I am convinced that the consistent implementation of BfArM – and VfARichtlinien by the pharmaceutical companies, as well as by the involved CROs, a key to the newfound confidence is,”said Nicole Tappee, head of clinical services GmbH. it applies research organization (CRO) for the DocCheck medical to remain and continue to improve the quality and transparency of the studies. In particular for new active ingredient group respondents gave a great importance of non – Interventional study.

66 percent felt that NIS just for new active ingredient groups are important. 22 percent of them gave even their full consent. NIS are essential to determine the benefits of treatment measures in the wide, routine application and to detect rare ADRs where the advantage here is not as far as possible interference of the doctor,”Michael holds Bonn, medical and Scientific Director of Rottapharm Madaus, fixed. Pharmaceutical companies are in the duty to ensure this instrument of research and development through a high quality criteria, as well as transparency, to the value of the generated Data to substantiate.” The survey was conducted by the DocCheck market research and can be requested at. Doccheck medical services GmbH DocCheck is the largest Internet community for healthcare professionals in Europe with more than 670,000 members. In the healthcare market, DocCheck thus has an average range: almost every second doctor or pharmacist in Germany is member of doccheck. DocCheck offers its members various information products and services around the topic of healthcare. In addition users via the DocCheck login access to the expert areas by over 2,200 affiliated medical websites. Online advertising, online market research and online surveys are among the most important business models by DocCheck. A growing number of pharmaceutical companies use the opportunity to communicate with their target audience using DocCheck without wastage. Press contact DocCheck CRO, Nicole Tappee, bird’s anger str. 66, 50823 Cologne, fon: + 49-221-92053-318, fax: + 49-221-92053-133, eMail:, home: DocCheck AG, Tanja Mumme, corporate communications, bird’s anger str. 66, 50823 Cologne, fon: + 49-221-92053-139, fax: + 49-221-92053-133, eMail:, home: